Elina Nalibotski

Elina Nalibotski is an accomplished professional with extensive experience in pharmaceutical and biotechnology industries. Currently serving as Senior Director of Global Early Pipeline in CNS at Otsuka Pharmaceutical Companies (U.S.) since October 2024, Elina has previously held significant roles at Agios Pharmaceuticals, including Director of Global Commercial Strategy & New Product Planning and Director of New Product Planning for Genetic Diseases, where strategic direction focused on developing innovative therapies for genetically defined diseases. Prior experience includes leadership roles at Vertex Pharmaceuticals, Ipsen, and Celgene, contributing to the marketing and expansion of transformative medicines in severe disease areas. Elina co-founded and served as President of Young Professionals in Healthcare, enhancing networking and career development for healthcare professionals. Educational credentials include an MBA from Harvard Business School and a B.S. in Molecular, Cellular, and Developmental Biology from Yale University.